Blue Crest Capital Management LTD Adamas Pharmaceuticals, Inc. Transaction History
Blue Crest Capital Management LTD
- $1.62 Billion
- Q3 2024
About Adamas Pharmaceuticals, Inc.
- Ticker ADMS
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,408,100
- Market Cap $376M